Complete remission of rare adenocarcinoma of the oropharynx with APCEDEN® (dendritic cell-based vaccine): a case report.

• 发表时间: 10 2017
• 来源期刊: Clin Case Rep
• DOI: 10.1002/ccr3.1169
• PMID: 29026574
• 文章类型: Case Reports
• 作者列表: Kumar C,Kohli S,Chiliveru S,Jain M,Sharan B

关键词: APCEDEN; dendritic cells; immunotherapy; oropharyngeal carcinoma; retromolar trigone

Abstract

APCEDEN ® is an autologous monocyte-derived dendritic cell-based immunotherapy. A 58-year-old man with adenocarcinoma of oropharynx shows complete remission after receiving APCEDEN ® in conjunction with Geftinib validated by reduction in size, whereas Gefitinib alone lead to disease progression.